MF
VERA icon

Magnetar Financial’s Vera Therapeutics VERA Stock Holding History

Magnetar Financial’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$257K Buy
+6,397
New +$276K ﹤0.01% 802
2025
Q2 		– Sell
-16,982
Closed -$408K – 1164
2025
Q1 		$408K Buy
+16,982
New +$546K 0.01% 504
2024
Q3 		– Sell
-18,021
Closed -$652K – 703
2024
Q2 		$652K Buy
+18,021
New +$715K 0.01% 312

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Magnetar Financial's VERA Position: Q1 2026 in Review

Magnetar Financial opened a new position in Vera Therapeutics (VERA) in Q1 2026: 6,397 shares worth $257K. The stake represents ﹤0.01% of the portfolio and ranks #802 among its holdings. This is a return to the name: Magnetar Financial previously reported a position in VERA as recently as Q1 2025.

Magnetar Financial first reported a position in VERA in Q2 2024 and has held it in 3 quarters since. The position peaked at $652K in Q2 2024. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Magnetar Financial held 6,397 shares of Vera Therapeutics worth $257K as of Q1 2026.
  • Vera Therapeutics was a new Magnetar Financial position in Q1 2026.
  • Vera Therapeutics made up ﹤0.01% of Magnetar Financial's portfolio in Q1 2026, its #802 holding.
  • Magnetar Financial first reported a position in Vera Therapeutics in Q2 2024 and has held it in 3 quarters since.
  • Magnetar Financial's Vera Therapeutics position peaked at $652K in Q2 2024.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Magnetar Financial's 13F filing for Q1 2026, filed 13 May 2026.